Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Biota Holdings Licenses Prostate Cancer Project
May 26th, 1997
Biota Holdings Limited, Melbourne, Australia, announced that it has signed an option agreement with two Japanese companies that could lead to the development of a new therapy for prostate cancer. The development program focuses on a group of compounds discovered to have anti-cancer properties by scientists at the Hitachi Chemical Research Center in Irvine, California. Normal cells in living tissue naturally die off in a programmed process called apoptosis, but cancer cells appear to lose their ability to die the way normal cells do. These compounds appear to reactivate the "death program" and therefore may have the capacity to restrict the growth or...
Source: Cancer Weekly (1997-05-26)
|
